179 related articles for article (PubMed ID: 6684988)
1. Phase II trial of mitomycin, vinblastine, and cisplatin (MVP) in non-small cell bronchogenic carcinoma.
Schulman P; Budman DR; Weiselberg L; Vinciguerra V; Degnan TJ
Cancer Treat Rep; 1983 Oct; 67(10):943-5. PubMed ID: 6684988
[TBL] [Abstract][Full Text] [Related]
2. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
[TBL] [Abstract][Full Text] [Related]
3. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
4. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
[TBL] [Abstract][Full Text] [Related]
5. High-dose cisplatin and vinblastine plus amifostine for metastatic non-small cell lung cancer.
Schiller JH
Semin Oncol; 1996 Aug; 23(4 Suppl 8):78-82. PubMed ID: 8783672
[TBL] [Abstract][Full Text] [Related]
6. [A combination chemotherapy using mitomycin C, vincristine and cisplatin (MVP) for advanced cervical cancer].
Ikeda K; Ogawa M; Inagaki J; Horikoshi N; Inoue K; Usui N; Nakada H; Adachi K; Yamazaki H; Tada A
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):536-40. PubMed ID: 4004284
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of mitomycin, vindesine, and hexamethylmelamine in metastatic non-small cell bronchogenic carcinoma.
Bonomi PD; Pazdur R; Stolbach L; Mason B; Ettinger D
Cancer Treat Rep; 1986 Dec; 70(12):1447-8. PubMed ID: 3024827
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of divided-dose vinblastine in non-small cell bronchogenic carcinoma.
Schulman P; Budman DR; Vinciguerra V; Weiselberg L; Abrams S; Degnan T
Cancer Treat Rep; 1982 Jan; 66(1):171-2. PubMed ID: 7053253
[TBL] [Abstract][Full Text] [Related]
9. Trial of vindesine, etoposide, and cisplatin in patients with previously treated, advanced-stage, non-small cell bronchogenic carcinoma.
Albain KS; Bitran JD; Golomb HM; Hoffman PC; DeMeester TR; Skosey C; Noble S; Blough RR
Cancer Treat Rep; 1984 Feb; 68(2):413-5. PubMed ID: 6538114
[TBL] [Abstract][Full Text] [Related]
10. Treatment of non-small cell bronchogenic carcinoma with vinblastine and mitomycin: a Southwest Oncology Group Study.
Weick JK; Rainey JM; Livingston RB; Baker LH; O'Bryan RM; Chen TT
Cancer Treat Rep; 1985 Jun; 69(6):583-5. PubMed ID: 2990709
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin, doxorubicin, cyclophosphamide, lomustine, and vincristine (PACCO) in the treatment of non-small cell bronchogenic carcinoma.
Whitehead RP; Rosenbaum PR; Carbone PP
Cancer Treat Rep; 1984 May; 68(5):771-3. PubMed ID: 6539171
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
[TBL] [Abstract][Full Text] [Related]
14. Ftorafur, adriamycin and mitomycin C (FAM II) for extensive bronchogenic adenocarcinoma and large cell carcinoma.
Salvati F; Cruciani AR; De Marinis A; Nunziati F; Portalone L
Jpn J Clin Oncol; 1984 Mar; 14(1):3-6. PubMed ID: 6323790
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of doxorubicin and mitomycin in non-small cell bronchogenic carcinoma.
Coates AS; Fox RM; Woods RL; Levi JA; Tattersall MH
Cancer Treat Rep; 1982 Jan; 66(1):177-8. PubMed ID: 7053255
[TBL] [Abstract][Full Text] [Related]
16. Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
Sculier JP; Lafitte JJ; Paesmans M; Thiriaux J; Alexopoulos CG; Baumöhl J; Schmerber J; Koumakis G; Florin MC; Zacharias C; Berghmans T; Mommen P; Ninane V; Klastersky J
Br J Cancer; 2000 Nov; 83(9):1128-35. PubMed ID: 11027424
[TBL] [Abstract][Full Text] [Related]
17. A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma.
O'Brien ME; Saini A; Smith IE; Webb A; Gregory K; Mendes R; Ryan C; Priest K; Bromelow KV; Palmer RD; Tuckwell N; Kennard DA; Souberbielle BE
Br J Cancer; 2000 Oct; 83(7):853-7. PubMed ID: 10970684
[TBL] [Abstract][Full Text] [Related]
18. High-dose cisplatin with fluid and mannitol-induced diuresis in advanced lung cancer: a phase II clinical trial of the EORTC Lung Cancer Working Party (Belgium).
De Jager R; Longeval E; Klastersky J
Cancer Treat Rep; 1980; 64(12):1341-6. PubMed ID: 6258791
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer. Final results of a multicenter phase II study.
Cigolari S; Curcio C; Maiorino A; Sessa R; Cioffi A; Massimo M
Anticancer Res; 2003; 23(2C):1803-9. PubMed ID: 12820462
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial.
Waller D; Peake MD; Stephens RJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG
Eur J Cardiothorac Surg; 2004 Jul; 26(1):173-82. PubMed ID: 15200998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
